Sequencing analysis with circulating DNA

Large disparities found in BCRA testing across ethnicities

Radiotherapy in Hogkin lymphoma: reducing risk in later life

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer

Multiplex IHC as biomarkers for cancer immunotherapy

Integrating multiple omics information in the era of precision oncology

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Mechanisms of immune escape in non-Hodgkin lymphoma

Innovations in assessing patient outcomes

Cancer cells plasticity and drug resistance

Drugging “undruggable” transcription factor drivers in cancer

Elucidation and pharmacological targeting of tumour checkpoint dependencies